Mailing of the Meeting materials has commenced, and Quorum Shareholders should receive them in due course. All of the Meeting materials can be accessed on Quorum’s corporate website ( ...
Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically, or directly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback